The relationship between symptoms and stress in adolescents with schizophrenia

Issues in Mental Health Nursing

Volumn 30, Issue 12, 2009, Pages 736-744

  Lee, Heeyoung ^a   Schepp, Karen ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE BEHAVIOR; ADOLESCENT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; MALE; MENTAL STRESS; NURSING; NURSING DIAGNOSIS; PROBLEM SOLVING; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCHIZOPHRENIA; SELF CARE; SOCIALIZATION;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NURSING DIAGNOSIS; PROBLEM SOLVING; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF CARE; SOCIALIZATION; STRESS, PSYCHOLOGICAL;

EID: 70450212545     PISSN: 01612840     EISSN: 10964673     Source Type: Journal    
DOI: 10.3109/01612840903200019     Document Type: Article

References (68)

1. American Academy of Child and Adolescent Psychiatry. (2001). Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. Journal of American Academy of Child and Adolescent Psychiatry, 40(7 suppl.), 4S-23S.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
3. Barbato, A., & D'Avanzo, B. (2000). Family interventions in schizophrenia and related disorders: A critical review of clinical trials. Acta Psychiatrica Scandinavica, 102(2), 81-97.
4. Basso, M. R., Nasrallah, H. A., Olson, S. C., & Bornstein, R. A. (1998). Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia. Schizophrenia Research, 31(2-3), 99-111.
5. Bebbington, P., Wilkins, S., Jones, P., Foerster, A., Murray, R., Toone, B., et al. (1993). Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study. British Journal of Psychiatry, 162, 72-79. (Pubitemid 23017017)
6. Bebbington, P., Wilkins, S., Sham, P., Jones, P., Van Os, J., Murray, R., et al. (1996). Life events before psychotic episodes: Do clinical and social variables affect the relationship? Social Psychiatry and Psychiatric Epidemiology, 31(3-4), 122-128.
7. Bergen, J., Hunt, G., Armitage, P., & Bashir, M. (1998). Six-month outcome following a relapse of schizophrenia. Australian and New Zealand Journal of Psychiatry, 32(6), 815-822.
8. Birchwood, M., Smith, J., Macmillan, F., Hogg, B., Prasad, R., Harvey, C., et al. (1989). Predicting relapse in schizophrenia: The development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation. Psychological Medicine, 19(3), 649-656.
9. Birchwood, M., & Spencer, E. (2001). Early intervention in psychotic relapse. Clinical Psychology Review, 21(8), 1211-1226.
10. Boden, R., Sundstrom, J., Lindstrom, E., & Lindstrom, L. (2008). Association between symptomatic remission and functional outcome in first-episode schizophrenia. Schizophrenia Research.
11. Byerly, M. J., Thompson, A., Carmody, T., Bugno, R., Erwin, T., Kashner, M., et al. (2007). Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatric Services, 58(6), 844-847.
12. Cannon, M., Jones, P., Huttunen, M. O., Tanskanen, A., Huttunen, T., Rabe- Hesketh, S., et al. (1999). School performance in Finnish children and later development of schizophrenia: A population-based longitudinal study. Archives of General Psychiatry, 56(5), 457-463.
13. Chambers,W. J., Puig-Antich, J., Hirsch,M., Paez, P., Ambrosini, P. J., Tabrizi, M. A., et al. (1985). The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version. Archives of General Psychiatry, 42(7), 696-702.
14. Dahl, R. E. (2004). Adolescent brain development: A period of vulnerabilities and opportunities. Keynote address. Annals of the New York Academy of Sciences, 1021(1), 1-22.
15. Das, M. K., Kulhara, P. L., & Verma, S. K. (1997). Life events preceding relapse of schizophrenia. Internal Journal of Social Psychiatry, 43(1), 56-63.
16. Dohrenwend, B. S., Dohrenwend, B. P., Dodson, M., & Shrout, P. E. (1984). Symptoms, hassles, social supports, and life events: Problem of confounded measures, Journal of Abnormal Psychology, 93(2), 222-230.
17. Eggert, L. L., Herting, J. R., & Thompson, E. A. (1996). The Drug Involvement Scale for Adolescents (DISA). Journal of Drug Education, 26(2), 101-130.
18. Fadden, G. (1998). Family intervention in psychosis. Journal of Mental Health, 7(2), 115-122.
19. Frazier, J. A., Alaghband-Rad, J., Jacobsen, L., Lenane, M. C., Hamburger, S., Albus, K., et al. (1997). Pubertal development and onset of psychosis in childhood onset schizophrenia. Psychiatry Research, 70(1), 1-7. (Pubitemid 27223984)
20. Gasquet, I., Haro, J. M., Novick, D., Edgell, E. T., Kennedy, L., & Lepine, J. P. (2005). Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: Results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study. International Clinical Psychopharmacology, 20(4), 199-205.
21. Hewitt, L., & Birchwood, M. (2002). Preventing relapse of psychotic illness: Role of self-monitoring of prodromal symptoms. Disease Management & Health Outcomes, 10, 395-407.
22. Hogarty, G. E.,Kornblith, S.J., Greenwald, D., DiBarry, A.L., Cooley, S., Ulrich, R.F. et al. (1997). Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rate. American Journal of Psychiatry, 154(11). 1504-1513. (Pubitemid 27471342)
23. Hollis, C. (2000). Adult outcomes of child- and adolescent-onset schizophrenia: Diagnostic stability and predictive validity. American Journal of Psychiatry, 157(10), 1652-1659.
24. Horan, W. P., & Blanchard, J. J. (2003). Emotional responses to psychosocial stress in schizophrenia: The role of individual differences in affective traits and coping. Schizophrenia Research, 60(2-3), 271-283.
25. Huxley, N. A., Rendall, M., & Sederer, L. (2000). Psychosocial treatments in schizophrenia: A review of the past 20 years. Journal of Nervous and Mental Disease, 188(4), 187-201.
26. Jorgensen, P. (1998a). Early signs of psychotic relapse in schizophrenia. British Journal of Psychiatry, 172, 327-330.
27. Jorgensen, P. (1998b). Schizophrenic delusions: The detection of warning signals. Schizophrenia Research, 32(1), 17-22.
28. Kanner, A. D., Coyne, J. C., Schaefer, C., & Lazarus, R. S. (1981). Comparison of two modes of stress measurement: Daily hassles and uplifts versus major life events. Journal of Behavioral Medicine, 4(1), 1-39.
29. Kennedy, M. (1994). Relapse in schizophrenia: The relationships among insight, symptom recognition, symptom self-management, and perceived effectiveness of symptom self-management at the time of hospitalization. Unpublished doctoral dissertation, University of Washington, Seattle.
30. Kenny, J. T., Friedman, L., Findling, R. L., Swales, T. P., Strauss, M. E., Jesberger, J. A., et al. (1997). Cognitive impairment in adolescents with schizophrenia. American Journal of Psychiatry, 154(11), 1613-1615.
31. Kyriakopoulos, M., & Frangou, S. (2007). Pathophysiology of early onset schizophrenia. International Review of Psychiatry, 19(4), 315-324.
32. Lay, B., Blanz, B., Hartmann, M., & Schmidt, M. H. (2000). The psychosocial outcome of adolescent-onset schizophrenia:A12-year follow-up. Schizophrenia Bulletin, 26(4), 801-816.
33. Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal, and coping. NewYork: Springer.
34. Lee, C.,McGlashan, T. H., & Woods, S.W. (2005). Prevention of schizophrenia: Can it be achieved? CNS Drugs, 19(3), 193-206.
35. Leucht, S., Barnes, T. R., Kissling, W., Engel, R. R., Correll, C., & Kane, J. M. (2003). Relapse prevention in schizophrenia with new-generation antipsychotics: A systematic review and exploratory meta-analysis of randomized, controlled trials. American Journal of Psychiatry, 160(7), 1209-1222.
36. Lieberman, J. A., Perkins, D., Belger, A., Chakos, M., Jarskog, F., Boteva, K., et al. (2001). The early stages of schizophrenia: Speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biological Psychiatry, 50(11), 884-897.
37. Linszen, D., Dingemans, P., & Lenior, M. (2001). Early intervention and a five year follow up in young adults with a short duration of untreated psychosis: Ethical implications. Schizophrenia Research, 51(1), 55-61.
38. Linszen, D. H., Dingemans, P. M., Nugter, M. A., Van Der Does, A. J., Scholte, W. F., & Lenior, M. A. (1997). Patient attributes and expressed emotion as risk factors for psychotic relapse. Schizophrenia Bulletin, 23(1), 119-130.
39. Malla, A. K., Cortese, L., Shaw, T. S., & Ginsberg, B. (1990). Life events and relapse in schizophrenia. A one year prospective study. Social Psychiatry and Psychiatric Epidemiology, 25(4), 221-224.
40. Malla, A. K., & Norman, R. M. (1992). Relationship of major life events and daily stressors to symptomatology in schizophrenia. Journal of Nervous and Mental Disease, 180(10), 664-667.
41. McEvoy, J. P. (2008). Functional outcomes in schizophrenia. Journal of Clinical Psychiatry, 69(Suppl 3), 20-24.
42. Muller, N. (2004). Mechanisms of relapse prevention in schizophrenia. Pharmacopsychiatry, 37(Suppl 2), S141-S147.
43. Myin-Germeys, I., Krabbendam, L., Jolles, J., Delespaul, P. A., & Van Os, J. V. (2002). Are cognitive impairments associated with sensitivity to stress in schizophrenia? An experience sampling study. The American Journal of Psychiatry, 159(3), 443-449.
44. Myin-Germeys, I., Peeters, F., Havermans, R., Nicolson, N. A., DeVries, M. W., Delespaul, P., et al. (2003). Emotional reactivity to daily life stress in psychosis and affective disorder: An experience sampling study. Acta Psychiatrica Scandinavica, 107(2), 124-131. (Pubitemid 36164480)
45. Myin-Germeys, I.,&van Os, J. (2007). Stress-reactivity in psychosis: Evidence for an affective pathway to psychosis. Clinical Psychology Review, 27(4), 409-424.
46. Nicolson, R., Lenane, M., Singaracharlu, S., Malaspina, D., Giedd, J. N., Hamburger, S. D., et al. (2000). Premorbid speech and language impairments in childhood-onset schizophrenia: Association with risk factors. American Journal of Psychiatry, 157(5), 794-800.
47. Norman, R. M., & Malla, A. K. (1993a). Stressful life events and schizophrenia. I: A review of the research. British Journal of Psychiatry, 162, 161-166.
48. Norman, R. M., & Malla, A. K. (1993b). Stressful life events and schizophrenia. II: Conceptual and methodological issues. British Journal of Psychiatry, 162, 166-174.
49. Nuechterlein, K. H., Dawson, M. E., Gitlin, M., Ventura, J., Goldstein, M. J., Snyder, K. S., et al. (1992). Developmental processes in schizophrenic disorders: Longitudinal studies of vulnerability and stress. Schizophrenia Bulletin, 18(3), 387-425.
50. Pencer, A., Addington, J.,&Addington, D. (2005).Outcome of a first episode of psychosis in adolescence: A 2-year follow-up. Psychiatry Research, 133(1), 35-43. (Pubitemid 40215469)
51. Phillips, L. J.,McGorry, P. D., Garner, B., Thompson, K. N., Pantelis, C.,Wood, S. J., et al. (2006). Stress, the hippocampus and the hypothalamic-pituitaryadrenal axis: Implications for the development of psychotic disorders. Australian and New Zealand Journal of Psychiatry, 40(9), 725-741.
52. Robinson, D., Woerner, M. G., Alvir, J. M., Bilder, R., Goldman, R., Geisler, S., et al. (1999). Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry, 56(3), 241-247. (Pubitemid 29125132)
53. Schepp, K. G. (1993). Psychoeducation for families of mentally ill. Communicating Nursing Research, 26(1), 170.
54. Schepp, K. G., O'Connor, F., & Kennedy, M. G. (2005). Self-management therapy for youth with schizophrenia. Final report: Summary for NIMH Randomized Clinical trial #R01-MH56580. Submitted to the National Institute of Mental Health of the National Institute of Health, Bethesda, MD.
55. Schepp, K., O'Connor, F. W., & Kennedy, M. G. (2006). Family centered program for adolescents with schizophrenia. Intervention manual for NIMH RCT MH56580. Unpublished manual. University of Washington, Seattle, WA.
56. Serido, J.,Almeida, D. M.,& Wethington, E. (2004). Chronic stressors and daily hassles: Unique and interactive relationships with psychological distress. Journal of Health and Social Behavior, 45(1), 17-33.
57. Spear, L. P. (2000). The adolescent brain and age-related behavioral manifestations. Neuroscience and Behavioral Reviews, 24(4), 417-463.
58. Steinberg, L. (2005). Cognitive and affective development in adolescence. Trends in Cognitive Sciences, 9(2), 69-74.
59. Tsatsoulis, A., & Fountoulakis, S. (2006). The protective role of exercise on stress system dysregulation and comorbidities. Annals of New York Academy of Sciences, 1083, 196-213.
60. Ventura, J., Nuechterlein, K. H., Subotnik, K. L., Hardesty, J. P., & Mintz, J. (2000). Life events can trigger depressive exacerbation in the early course of schizophrenia. Journal of Abnormal Psychology, 109(1), 139-144.
61. Vourdas, A., Pipe, R., Corrigall, R., & Frangou, S. (2003). Increased developmental deviance and premorbid dysfunction in early onset schizophrenia. Schizophrenia Research, 62(1-2), 13-22.
62. Walker, E. F., & Bollini, A. M. (2002). Pubertal neurodevelopment and the emergence of psychotic symptoms. Schizophrenia Research, 54(1-2), 17-23.
63. Walker, E., Mittal, V., & Tessner, K. (2008). Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annual Review of Clinical Psychology, 4, 189-216.
64. Weiner, J. S. (1982). Child and adolescent pscyhpathology, New York: Wiley.
65. Werry, J. S. McClellan, J. M., & Chard, L. (1991). Childhood and adolescent schizophrenic, bipolar and schizoaffective disorder: A clinical and outcome study. Journal of the American Academy of Child and Adolescent Psychiatry, 30(3), 457-465.
66. World Health Organization. (2001). World Health Report 2001. Mental health: New understanding, new hope, Geneva: Author.
67. Wu, E. Q., Birnbaum, H. G., Zhang, H. F., Ivanova, J. I., Yang, E., & Mallet, D. (2007). Health care costs of adults treated for attention-deficit/ hyperactivity disorder who received alternative drug therapies. Journal of Managed Care Pharmacy, 13(7), 561-569.
68. Zubin, J., & Spring, B. (1977). Vulnerability-a new view of schizophrenia. Journal of Abnormal Psychology, 86(2), 103-126.